Kairos Hospice, Inc. 161 W Arrow Hwy, Glendora, CA, 91740 | |
(626) 335-8857 |
News Archive
In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development.
HighRes Biosolutions, the leader in laboratory automation for life sciences, announced today that it is building a system for an undisclosed laboratory in Shanghai, China. The new system will be installed in the fall of 2010 by HighRes and Tekon Biotech Ltd, the Asian distributor representing HighRes in this region.
Former Mass. Gov. Mitt Romney continues to aim criticism at the health law signed by President Barack Obama while former New York City Mayor Rudy Giuliani, who has not yet announced an intent to seek the GOP nomination, slammed the state law that Romney backed.
A team led by scientists at The Scripps Research Institute has solved the structure of one of the receptors that responds to the neurotransmitter dopamine. Although dopamine transmission is essential to normal brain functioning, the biological assembly of the molecules involved in this crucial neuronal interplay had not been known until now.
Brain imaging of pathological tau-protein "tangles" reliably predicts the location of future brain atrophy in Alzheimer's patients a year or more in advance, according to a new study by scientists at the UC San Francisco Memory and Aging Center. In contrast, the location of amyloid "plaques," which have been the focus of Alzheimer's research and drug development for decades, was found to be of little utility in predicting how damage would unfold as the disease progressed.
› Verified 8 days ago
Name | Kairos Hospice, Inc. |
---|---|
Location | 161 W Arrow Hwy, Glendora, California |
Hospice ID | 751598 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 200 |
News Archive
In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development.
HighRes Biosolutions, the leader in laboratory automation for life sciences, announced today that it is building a system for an undisclosed laboratory in Shanghai, China. The new system will be installed in the fall of 2010 by HighRes and Tekon Biotech Ltd, the Asian distributor representing HighRes in this region.
Former Mass. Gov. Mitt Romney continues to aim criticism at the health law signed by President Barack Obama while former New York City Mayor Rudy Giuliani, who has not yet announced an intent to seek the GOP nomination, slammed the state law that Romney backed.
A team led by scientists at The Scripps Research Institute has solved the structure of one of the receptors that responds to the neurotransmitter dopamine. Although dopamine transmission is essential to normal brain functioning, the biological assembly of the molecules involved in this crucial neuronal interplay had not been known until now.
Brain imaging of pathological tau-protein "tangles" reliably predicts the location of future brain atrophy in Alzheimer's patients a year or more in advance, according to a new study by scientists at the UC San Francisco Memory and Aging Center. In contrast, the location of amyloid "plaques," which have been the focus of Alzheimer's research and drug development for decades, was found to be of little utility in predicting how damage would unfold as the disease progressed.
› Verified 8 days ago
NPI Number | 1639416597 |
Organization Name | Kairos Hospice Incorporation |
Address | 161 W Arrow Hwy Glendora, California, 91740 |
Phone Number | (626)422-8056 |
News Archive
In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development.
HighRes Biosolutions, the leader in laboratory automation for life sciences, announced today that it is building a system for an undisclosed laboratory in Shanghai, China. The new system will be installed in the fall of 2010 by HighRes and Tekon Biotech Ltd, the Asian distributor representing HighRes in this region.
Former Mass. Gov. Mitt Romney continues to aim criticism at the health law signed by President Barack Obama while former New York City Mayor Rudy Giuliani, who has not yet announced an intent to seek the GOP nomination, slammed the state law that Romney backed.
A team led by scientists at The Scripps Research Institute has solved the structure of one of the receptors that responds to the neurotransmitter dopamine. Although dopamine transmission is essential to normal brain functioning, the biological assembly of the molecules involved in this crucial neuronal interplay had not been known until now.
Brain imaging of pathological tau-protein "tangles" reliably predicts the location of future brain atrophy in Alzheimer's patients a year or more in advance, according to a new study by scientists at the UC San Francisco Memory and Aging Center. In contrast, the location of amyloid "plaques," which have been the focus of Alzheimer's research and drug development for decades, was found to be of little utility in predicting how damage would unfold as the disease progressed.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development.
HighRes Biosolutions, the leader in laboratory automation for life sciences, announced today that it is building a system for an undisclosed laboratory in Shanghai, China. The new system will be installed in the fall of 2010 by HighRes and Tekon Biotech Ltd, the Asian distributor representing HighRes in this region.
Former Mass. Gov. Mitt Romney continues to aim criticism at the health law signed by President Barack Obama while former New York City Mayor Rudy Giuliani, who has not yet announced an intent to seek the GOP nomination, slammed the state law that Romney backed.
A team led by scientists at The Scripps Research Institute has solved the structure of one of the receptors that responds to the neurotransmitter dopamine. Although dopamine transmission is essential to normal brain functioning, the biological assembly of the molecules involved in this crucial neuronal interplay had not been known until now.
Brain imaging of pathological tau-protein "tangles" reliably predicts the location of future brain atrophy in Alzheimer's patients a year or more in advance, according to a new study by scientists at the UC San Francisco Memory and Aging Center. In contrast, the location of amyloid "plaques," which have been the focus of Alzheimer's research and drug development for decades, was found to be of little utility in predicting how damage would unfold as the disease progressed.
› Verified 8 days ago
Home Health Aides | 1 |
Counselors | 1 |
Licensed Practical or Vocational Nurses | 1 |
Medical Social Workers | 1 |
Registered Nurses | 1 |
Total Employees | 5 |
---|
News Archive
In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development.
HighRes Biosolutions, the leader in laboratory automation for life sciences, announced today that it is building a system for an undisclosed laboratory in Shanghai, China. The new system will be installed in the fall of 2010 by HighRes and Tekon Biotech Ltd, the Asian distributor representing HighRes in this region.
Former Mass. Gov. Mitt Romney continues to aim criticism at the health law signed by President Barack Obama while former New York City Mayor Rudy Giuliani, who has not yet announced an intent to seek the GOP nomination, slammed the state law that Romney backed.
A team led by scientists at The Scripps Research Institute has solved the structure of one of the receptors that responds to the neurotransmitter dopamine. Although dopamine transmission is essential to normal brain functioning, the biological assembly of the molecules involved in this crucial neuronal interplay had not been known until now.
Brain imaging of pathological tau-protein "tangles" reliably predicts the location of future brain atrophy in Alzheimer's patients a year or more in advance, according to a new study by scientists at the UC San Francisco Memory and Aging Center. In contrast, the location of amyloid "plaques," which have been the focus of Alzheimer's research and drug development for decades, was found to be of little utility in predicting how damage would unfold as the disease progressed.
› Verified 8 days ago
Community Care Hospice Location: 222 W Foothill Blvd, Glendora, California, 91741 Phone: (626) 335-8857 |
Priority Hospice Care, Inc Location: 1285 East Route 66, Glendora, California, 91740 Phone: (626) 335-8857 |
San Gabriel Hospice Location: 1152 E Route 66, Glendora, California, 91740 Phone: (626) 335-8857 |
Kairos Hospice, Inc. Location: 161 W Arrow Hwy, Glendora, California, 91740 Phone: (626) 335-8857 |